NexImmune, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NexImmune, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • NexImmune, Inc. Return On Equity for the quarter ending June 30, 2024 was -542 %, a 235% decline year-over-year.
  • NexImmune, Inc. annual Return On Equity for 2023 was -247 %, a 104% decline from 2022.
  • NexImmune, Inc. annual Return On Equity for 2022 was -121 %, a 145% decline from 2021.
  • NexImmune, Inc. annual Return On Equity for 2021 was -49.5 %, a 198% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -542 -381 -235% Apr 1, 2024 Jun 30, 2024
Q1 2024 -328 -185 -129% Jan 1, 2024 Mar 31, 2024
Q4 2023 -247 -126 -104% Oct 1, 2023 Dec 31, 2023
Q3 2023 -216 -121 -128% Jul 1, 2023 Sep 30, 2023
Q2 2023 -162 -82.2 -103% Apr 1, 2023 Jun 30, 2023
Q1 2023 -143 -79.6 -125% Jan 1, 2023 Mar 31, 2023
Q4 2022 -121 -71.7 -145% Oct 1, 2022 Dec 31, 2022
Q3 2022 -94.9 -27.7 -41.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -79.5 +72.7 +47.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -63.6 -257 -133% Jan 1, 2022 Mar 31, 2022
Q4 2021 -49.5 -100 -198% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.2 Jul 1, 2021 Sep 30, 2021
Q2 2021 -152 Apr 1, 2021 Jun 30, 2021
Q1 2021 194 Jan 1, 2021 Mar 31, 2021
Q4 2020 50.7 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.